Health span extension through green chemoprevention

Virtual Mentor

Volumn 15, Issue 4, 2013, Pages 311-318

  Fahey, Jed W ^a   Kensler, Thomas W ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLANT MEDICINAL PRODUCT;

ARTICLE; CHEMOPROPHYLAXIS; DIET; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; LONGEVITY; METHODOLOGY; NEOPLASM; PREVENTIVE MEDICINE;

ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; DIET; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; LONGEVITY; NEOPLASMS; PLANT PREPARATIONS; PREVENTIVE MEDICINE;

EID: 84884376302     PISSN: 19377010     EISSN: None     Source Type: Journal    
DOI: 10.1001/virtualmentor.2013.15.4.stas1-1304     Document Type: Review

References (32)

1. Perkins HS. Patients are hardly too thin or too rich-doctors' preventive medicine duties. Virtual Mentor. 2008;10(11):750-755.
2. Hull SK. A larger role for preventive medicine. Virtual Mentor. 2008;10(11):724-729.
3. National Cancer Institute. 2011 Fact Book. http://obf.cancer.gov/financial/attachments/11Factbk.pdf. Accessed March 15, 2013.
4. Lavizzo-Mourey R. We must focus on preventing disease if we want our nation to thrive. The Atlantic. May 30, 2012. http://www.theatlantic.com/health/archive/2012/05/we-must-focus-onpreventing-disease-if-we-want-our-nation-to-thrive/257759/. Accessed March 15, 2013.
5. Gusmano MK. Power, politics, and health spending priorities. Virtual Mentor. 2012;14(11):885-889.
6. Mattke S, Klantzer LK, Mengistu T, Garnett J, Hu J, Wu H. Health and well-being in the home: a global analysis of needs, expectations, and priorities for home health care technology. Santa Monica, CA: RAND Corporation; 2010. http://www.rand.org/content/dam/rand/pubs/occasional_papers/2010/RAND_OP323.pdf. Accessed March 15, 2013.
7. Agus DB. The End of Illness. New York: Free Press; 2012.
8. O'Callaghan T. Introduction: the prevention agenda. Nature. 2011;471(7339):S2-S4.
9. Bloom DE, Cafiero ET, Jane-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum; 2011. http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf. Accessed March 15, 2013.
10. Smith R. Why a macroeconomic perspective is critical to the prevention of noncommunicable disease. Science. 2012;337(6101):1501-1503.
11. Lingwood RJ, Boyle P, Milburn A, et al. The challenge of cancer control in Africa. Nature Rev Cancer. 2008;8(5):398-403.
12. Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res. 2008;52 Suppl 1:S128-S138.
13. Kensler TW, Wakabayashi N. Nrf2: Friend or foe for chemoprevention? Carcinogenesis. 2010;31(1):90-99.
14. Lee KW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer. 2011;11(3):211-218.
15. Sporn MB. The big C-for chemoprevention. Nature. 2011;471(7339):s10-s11.
16. Hecht SS. Tackling the real issues. Nature. 2011;471(7339):S18.
17. Liu H, Dinkova-Kostova AT, Talalay P. Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles. Proc Natl Acad Sci U S A. 2008;105(41):15926-15931.
18. Talalay P, Dinkova-Kostova AT, Holtzclaw WD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul. 2003;43:121-134.
19. Fahey JW, Talalay P, Kensler TW. Notes from the field: “green” chemoprevention as frugal medicine. Cancer Prev Res (Phila). 2012;5(2):179-188.
20. Kensler TW, Roebuck BD, Wogan GN, Groopman JD. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci. 2011;120 Suppl 1:S28-S48.
21. Fahey JW, Kensler TW. Role of dietary supplements/nutraceuticals in chemoprevention through induction of cytoprotective enzymes. Chem Res Toxicol. 2007;20(4):572-576.
22. Marteau TM, Hollands GJ, Fletcher PC. Changing human behavior to prevent disease: the importance of targeting automatic processes. Science. 2012;337(6101):1492-1495.
23. Ezzati M, Riboli E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science. 2012;337(6101):1482-1487.
24. Couzin-Frankel J. Tackling America's eating habits, one store at a time. Science. 2012;337(6101):1473-1475.
25. Kensler TW, Ng D, Carmella SG, et al. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis. 2012;33(1):101-107.
26. Boysen G, Kenney PMJ, Upadhyaya P, Wang M, Hecht SS. Effects of benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism in F-344 rats. Carcinogenesis. 2003;24(3):517-525.
27. Woolf SH, Husten CG, Lewin LS, Marks JS, Fielding JE, Sanchez EJ. The economic argument for disease prevention: distinguishing between value and savings. http://www.prevent.org/data/files/initiatives/economicargumentfordiseaseprevention.pdf. Partnership for Prevention; 2009. Accessed December 4, 2012.
28. Woolf SH. A closer look at the economic argument for disease prevention. JAMA. 2009;301(5):536-538.
29. Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995;15(3):369-390.
30. Norum J. Prevention of colorectal cancer: a cost-effectiveness approach to a screening model employing sigmoidoscopy. Ann Oncol. 1998;9(6):617.
31. Lowenstein R. The quality cure? New York Times Magazine. March 13, 2005: 46-53. http://www.nytimes.com/2005/03/13/magazine/13HEALTH.html?_r=0. Accessed March 15, 2013.
32. Centers for Disease Control, Division for Heart Disease & Stroke Prevention. About us. http://www.cdc.gov.dhdsp/about_us.htm. Accessed Dec 4, 2012.